Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04417283 · ClinicalTrials.gov registry record

Project HOPE 1000: Health Outcomes Pregnancy Exposures

A clinical trial of Pregnant, sponsored by Duke University.

Active
Registry status
1,000
Enrollment target
1
Study location

NCT04417283: Active study of Pregnant, sponsored by Duke University.

NCT04417283 is a study of Pregnant that is active but no longer recruiting, run by Duke University. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04417283, a study of Pregnant, is active but no longer recruiting, sponsored by Duke University.

ACTIVE NOT RECRUITING
Registry status
1,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to collect biological samples from pregnant women and their babies and to collect data on long-term health, school outcomes, and the use of state and county services. The information learned from this study may help identify important factors that may influence the health of mothers and babies, both short-and long-term.

Conditions Studied

Study Locations (1)

North Carolina

  • Duke affiliated ObGyn clinics within Duke Health - Durham

Trial Details

FieldValue
Enrollment Target 1,000 participants
Start Date 2018-11-21
Est. Completion 2027-03-01
Duke University

1,725 total trials

What the registry record for NCT04417283 still lists

NCT04417283 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Pregnant appearing as the primary indexed condition, and to 0 interventions.

NCT04417283 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT04417283 about?

NCT04417283 is a clinical study titled "Project HOPE 1000: Health Outcomes Pregnancy Exposures". The purpose of this study is to collect biological samples from pregnant women and their babies and to collect data on long-term health, school outcomes, and the use of state and county services. The information learned from this study may help identify important factors that may influence the healt...

What is the current status of trial NCT04417283?

This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2018-11-21. Estimated completion is 2027-03-01.

What conditions does trial NCT04417283 study?

This clinical trial studies the following conditions: Pregnant.

Who is sponsoring clinical trial NCT04417283?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04417283 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnant

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00018044 · 1,000 participants

    Study of Mycobacterial Infections

  • NCT01036581 · 1,000 participants · NA

    Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging

  • NCT01192048 · 1,000 participants

    Genetics of Congenital Heart Disease

  • NCT01553214 · 1,000 participants · Phase 4

    Improving White Blood Cell Collection From Healthy Donors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04417283, the US trial registry maintained by the National Library of Medicine. NCT04417283 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.